证券记录 · 已归档季度
GERN
Geron Corporation · Healthcare · Biotechnology
9被追踪持有人
—Δ持有人
67.08M持有股份
$284.41M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 91 | +1 | 281.46M | $360.40M | +7 | −6 |
| Q1 2026 | 93 | -3 | 271.64M | $404.62M | +7 | −10 |
| Q4 2025 | 95 | -3 | 246.07M | $324.82M | — | −3 |
| Q3 2025 | 17 | 0 | 193.54M | $265.15M | +2 | −2 |
| Q2 2025 | 14 | +1 | 162.89M | $229.67M | +1 | — |
| Q1 2025 | 10 | -1 | 76.28M | $121.30M | — | −1 |
| Q4 2024 | 11 | +1 | 96.17M | $340.44M | +2 | −1 |
| Q3 2024 | 9 | 0 | 71.98M | $326.79M | +2 | −2 |
| Q2 2024 | 9 | — | 67.08M | $284.41M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 19.73M | — | $83.63M | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 12.84M | — | $54.44M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 12.84M | — | $54.44M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 12.09M | — | $51.27M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 12.09M | — | $51.27M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 12.09M | — | $51.27M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 12.09M | — | $51.27M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 12.09M | — | $51.27M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 12.09M | — | $51.27M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 11.28M | — | $47.82M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 11.28M | — | $47.82M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 7.65M | — | $32.44M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 2.27M | — | $9.61M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 2.27M | — | $9.61M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 781.72K | — | $3.31M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 404.62K | — | $1.72M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 41.24K | — | $174,879 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 41.24K | — | $174,879 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 41.24K | — | $174,879 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 253 持有人, 492.17M 股份, $730.64M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据